BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
2506996
Number of visits today
751
Number of downloads
1688881
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Chen W, Li J, Li C, Fan HN, Zhang J, Zhu JS. Network pharmacology-based identification of the antitumor effects of taraxasterol in gastric cancer. Int J Immunopathol Pharmacol 2020;34:2058738420933107. [PMID: 32701378 DOI: 10.1177/2058738420933107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Zhang L, Guo M, Yang H. Taraxasterol suppresses cell proliferation and boosts cell apoptosis via inhibiting GPD2-mediated glycolysis in gastric cancer. Cytotechnology 2021;73:815-25. [PMID: 34776631 DOI: 10.1007/s10616-021-00499-8] [Reference Citation Analysis]
2 Jiao F, Tan Z, Yu Z, Zhou B, Meng L, Shi X. The phytochemical and pharmacological profile of taraxasterol. Front Pharmacol 2022;13:927365. [DOI: 10.3389/fphar.2022.927365] [Reference Citation Analysis]
3 Song Y, Chang L, Wang X, Tan B, Li J, Zhang J, Zhang F, Zhao L, Liu G, Huo B. Regulatory Mechanism and Experimental Verification of Patchouli Alcohol on Gastric Cancer Cell Based on Network Pharmacology. Front Oncol 2021;11:711984. [PMID: 34540679 DOI: 10.3389/fonc.2021.711984] [Reference Citation Analysis]
4 Qian X, Zhang L, Xie F, Cheng Y, Cui D. Network-Based Pharmacological Study on the Mechanism of Guishao-Liujun Decoction in the Treatment of Gastric Cancer. Front Pharmacol 2022;13:937439. [DOI: 10.3389/fphar.2022.937439] [Reference Citation Analysis]
5 Tang CT, Yang J, Liu ZD, Chen Y, Zeng C. Taraxasterol acetate targets RNF31 to inhibit RNF31/p53 axis-driven cell proliferation in colorectal cancer. Cell Death Discov 2021;7:66. [PMID: 33824292 DOI: 10.1038/s41420-021-00449-5] [Reference Citation Analysis]
6 Liu W, Yu Q, Wang F, Li Y, Zhang G, Tao S. Taraxasterol attenuates melanoma progression via inactivation of reactive oxygen species-mediated PI3K/Akt signaling pathway. Hum Exp Toxicol 2022;41:9603271211069034. [PMID: 35128947 DOI: 10.1177/09603271211069034] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345